We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on vaccination of children aged 12 to 15.
The JCVI is seeking evidence to inform possible changes to the HPV immunisation programme. We would like evidence around one-dose schedules for the HPV vaccine.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.
The Joint Committee on Vaccination and Immunisation (JCVI) statement on extending human papillomavirus (HPV) vaccinations to men who have sex with men.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for spring 2024 and beyond.
The Joint Committee on Vaccination and Immunisation (JCVI) advises the UK government on vaccination and immunisation matters.
A position statement on extending the annual influenza vaccination programme to children released by JCVI.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination in children and young people aged 16 to 17 years.
Interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the effectiveness of the COVID-19 booster vaccination programme on the Omicron variant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).